← Back to Search

Behavioral Intervention

Experimental: 3RP treatment for Stress (ASD Trial)

N/A
Waitlist Available
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Being the parent of at least one child with a diagnosed autism spectrum disorder
Age 18 or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change between baseline (week 0) to post intervention (week 12)
Awards & highlights
No Placebo-Only Group

ASD Trial Summary

This study has three aims: Phase I: Through focus group interviews with expert clinicians, leaders of organizations, and parents with children with ASD, this study aims to identify the psychosocial needs of parents of children with ASD, specifically a) the types of concerns that parents find most difficult and stressful b) areas of concern that lack support and resources, and c) areas of need for education and skill training. This study also aims to gather feedback on the Benson-Henry Institute's Relaxation Response Resiliency Program (3RP). Phase II: Informed by Phase I findings, this study aims to develop and determine the feasibility and acceptability of a virtual 8-session Relaxation Response Resiliency (3RP) program for parents of children with ASD. Phase II: This study also aims to test the effectiveness of a pilot wait-list control trial, establishing efficacy of a virtual resiliency program.

Eligible Conditions
  • Stress

ASD Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

ASD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change between baseline (week 0) to post intervention (week 12)
This trial's timeline: 3 weeks for screening, Varies for treatment, and change between baseline (week 0) to post intervention (week 12) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Distress Tolerance
Secondary outcome measures
Stress Reactivity

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

ASD Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Experimental: 3RP treatmentExperimental Treatment1 Intervention
An adapted version of the Relaxation Response Resiliency Program (3RP) for parents of children with ASD. The adapted program incorporates the three prongs of the 3RP: RR elicitation, stress awareness, and adaptive strategies.
Group II: Waitlist controlActive Control1 Intervention
An adapted version of the Relaxation Response Resiliency Program (3RP) for parents of children with ASD. The adapted program incorporates the three prongs of the 3RP: RR elicitation, stress awareness, and adaptive strategies.

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,908 Previous Clinical Trials
13,186,343 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~7 spots leftby Feb 2025